Asraj Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.05 Cr
as on 10-12-2024
- Revenue 191.42%
(FY 2022)
- Profit 275.65%
(FY 2022)
- Ebitda 29.14%
(FY 2022)
- Net Worth 6.84%
(FY 2022)
- Total Assets -3.38%
(FY 2022)
About Asraj Healthcare
The Corporate was formerly known as Asraj Properties Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.05 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pankaj Ahire, Harshad Argekar, Dilip Rajpal, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85100MH2010PTC201921
- Company No.
201921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Asraj Healthcare?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Ahire  | Director | 15-Jan-2022 | Current |
| Harshad Argekar | Director | 15-Jan-2022 | Current |
| Dilip Rajpal | Director | 15-Jan-2022 | Current |
| Sudhir Sharan | Director | 15-Jan-2022 | Current |
| Jaydeep Khedkar | Director | 12-Apr-2010 | Current |
| Reshama Argekar | Additional Director | 08-Feb-2020 | Current |
Financial Performance of Asraj Healthcare.
Asraj Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 191.42% increase. The company also saw a substantial improvement in profitability, with a 275.65% increase in profit. The company's net worth moved up by a moderate rise of 6.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asraj Healthcare?
In 2018, Asraj Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bajaj Finance Limited Creation Date: 29 Nov 2010 | ₹1.05 Cr | Satisfied |
How Many Employees Work at Asraj Healthcare?
Unlock and access historical data on people associated with Asraj Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asraj Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asraj Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
